Literature DB >> 28543694

Genetically engineered mouse models of melanoma.

Eva Pérez-Guijarro1, Chi-Ping Day1, Glenn Merlino1, M Raza Zaidi2.   

Abstract

Melanoma is a complex disease that exhibits highly heterogeneous etiological, histopathological, and genetic features, as well as therapeutic responses. Genetically engineered mouse (GEM) models provide powerful tools to unravel the molecular mechanisms critical for melanoma development and drug resistance. Here, we expound briefly the basis of the mouse modeling design, the available technology for genetic engineering, and the aspects influencing the use of GEMs to model melanoma. Furthermore, we describe in detail the currently available GEM models of melanoma. Cancer 2017;123:2089-103.
© 2017 American Cancer Society. © 2017 American Cancer Society.

Entities:  

Keywords:  carcinogen; genetically engineered mice; melanoma; mouse models; ultraviolet (UV) radiation

Mesh:

Year:  2017        PMID: 28543694      PMCID: PMC5445933          DOI: 10.1002/cncr.30684

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  106 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.

Authors:  A Birck; V Ahrenkiel; J Zeuthen; K Hou-Jensen; P Guldberg
Journal:  J Invest Dermatol       Date:  2000-02       Impact factor: 8.551

3.  Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.

Authors:  Damia Tormo; Aleix Ferrer; Evelyn Gaffal; Jörg Wenzel; Etiena Basner-Tschakarjan; Julia Steitz; Lukas C Heukamp; Ines Gütgemann; Reinhard Buettner; Marcos Malumbres; Mariano Barbacid; Glenn Merlino; Thomas Tüting
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 4.  Melanocyte biology and skin pigmentation.

Authors:  Jennifer Y Lin; David E Fisher
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

5.  Invasive melanoma in Cdk4-targeted mice.

Authors:  R Sotillo; J F García; S Ortega; J Martin; P Dubus; M Barbacid; M Malumbres
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 7.  Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function.

Authors:  John D Simon; Dana Peles; Kazumasa Wakamatsu; Shosuke Ito
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-21       Impact factor: 4.693

8.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.

Authors:  Xiaodong Feng; Maria Sol Degese; Ramiro Iglesias-Bartolome; Jose P Vaque; Alfredo A Molinolo; Murilo Rodrigues; M Raza Zaidi; Bruce R Ksander; Glenn Merlino; Akrit Sodhi; Qianming Chen; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2014-05-29       Impact factor: 31.743

9.  Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.

Authors:  Norman Edward Sharpless; Karuppiah Kannan; Jin Xu; Marcus Wolfram Bosenberg; Lynda Chin
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

Review 10.  Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.

Authors:  Andrea J McKinney; Sheri L Holmen
Journal:  Chin J Cancer       Date:  2011-03
View more
  26 in total

Review 1.  Model Systems for the Study of Malignant Melanoma.

Authors:  Randal K Gregg
Journal:  Methods Mol Biol       Date:  2021

Review 2.  The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance.

Authors:  Gennie L Parkman; Mona Foth; David A Kircher; Sheri L Holmen; Martin McMahon
Journal:  Exp Dermatol       Date:  2021-11-09       Impact factor: 3.960

Review 3.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

4.  Developmental chromatin programs determine oncogenic competence in melanoma.

Authors:  Arianna Baggiolini; Scott J Callahan; Lorenz Studer; Richard M White; Emily Montal; Joshua M Weiss; Tuan Trieu; Mohita M Tagore; Sam E Tischfield; Ryan M Walsh; Shruthy Suresh; Yujie Fan; Nathaniel R Campbell; Sarah C Perlee; Nathalie Saurat; Miranda V Hunter; Theresa Simon-Vermot; Ting-Hsiang Huang; Yilun Ma; Travis Hollmann; Satish K Tickoo; Barry S Taylor; Ekta Khurana; Richard P Koche
Journal:  Science       Date:  2021-09-03       Impact factor: 63.714

Review 5.  Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Med Sci (Basel)       Date:  2017-11-20

Review 6.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

7.  Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis.

Authors:  Charles-Antoine Assenmacher; Sara F Santagostino; Mark A Oyama; Jean-Christophe Marine; Elise Bonvin; Enrico Radaelli
Journal:  J Histochem Cytochem       Date:  2020-12-07       Impact factor: 2.479

Review 8.  The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery.

Authors:  Natalia V Segatto; Mariana H Remião; Kyle M Schachtschneider; Fabiana K Seixas; Lawrence B Schook; Tiago Collares
Journal:  Front Pharmacol       Date:  2017-12-05       Impact factor: 5.810

Review 9.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 10.  Modeling metastasis in mice: a closer look.

Authors:  Arianna Giacobbe; Cory Abate-Shen
Journal:  Trends Cancer       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.